A 78-year-old man with a history of heart failure presents for routine follow-up 1 week after insertion of a pacemaker. As part of the evaluation, a 12-lead ECG is obtained. The correct diagnosis is ...
LOS ANGELES, CA - June 3, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced that a peer ...
UC Berkeley researchers trained AI to detect hidden warning signs of sudden cardiac death in routine ECG tests, according to ...
Austin, Texas, July 1st, 2026, FinanceWireAdvances in digital health, cloud computing and data analytics are making it ...
In patients with symptoms such as irregular heartbeats, dizziness, or fainting, or in individuals that physicians suspect may have atrial fibrillation, many days of ECGs may be required for diagnosis ...
HeartBeam (NASDAQ: BEAT) announced it has received FDA 510(k) clearance for its flagship ECG system, a first-of-its-kind, credit card-sized, cable-free device designed to deliver high-fidelity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results